Key facts
- It has raised $3.1M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Climate Capital, University of California, Unlock Capital (New York), Embark Ventures, Juniper (San Francisco) — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Izote Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Izote Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Izote Biosciences
Developer of an oxygen-free industrial fermentation platform designed to improve the production of chemicals, fuels, and food ingredients. The company offers integrated strain engineering and process design for simpler operations and improved unit economics, enabling manufacturers of oxidation-sensitive, volatile, or energy-intensive products to reduce scale-up risk and access cost-sensitive markets through biomanufacturing.
- Sector
- Materials and Resources
- HQ
- Berkeley, CA, United States
- Founded
- 2022
- Employees
- 6
- Website
- izote.bio/
- Ownership
- Privately Held (backing)
Izote Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Izote Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Izote Biosciences in its N-PORT filings yet. We sweep new filings monthly.